EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

Ascorbic Acid for Methemoglobinemia Treatment: A Case Report and Literature Review

Kelli R Keats iD, Rachel Robinson, Mallika Patel, Alexis Wallace, Stephanie Albrecht

Journal of Pharmacy Practice · 2024

DOI: 10.1177/08971900231188834 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Pharmacy Practice, 2024. Verfasst von Kelli R Keats und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Augusta University Medical Center, Augusta, GA, USA. Hauptthemen laut MEDLINE: Anesthetics, Local, Ascorbic Acid, Benzocaine, Methemoglobinemia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Ascorbic acid has been proposed as an alternative treatment for methemoglobinemia in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency. However, its efficacy has never been compared to that of methylene blue given the inability of patients with G6PD deficiency to receive methylene blue. We present a case of methemoglobinemia treated with ascorbic acid in a patient without G6PD deficiency who had previously received methylene blue. Summary: A 66-year-old male was treated for methemoglobinemia deemed to be secondary to benzocaine throat spray. He received intravenous (IV) methylene blue but had a severe reaction: diaphoresis, lightheadedness, and hypotension. The infusion was stopped prior to completion. Approximately 6 days later he presented with methemoglobinemia following an additional overconsumption of benzocaine and was treated with ascorbic acid. In both instances his methemoglobin levels were >30% on arterial blood gas on admission and decreased to 6.5% and 7.8%, respectively, after administration of methylene blue and ascorbic acid.

Conclusion

Ascorbic acid had a similar effect on decreasing the concentration of methemoglobin compared to methylene blue. Further research into use of ascorbic acid as a recommended agent for treatment of methemoglobinemia is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anesthetics, LocalAscorbic AcidBenzocaineMethemoglobinemiaMethylene BlueAgedHumansMaleGlucosephosphate Dehydrogenase DeficiencyTreatment Outcome

Stichwörter der Autor:innen

critical caredrug informationemergency medicine

Substanzen

Anesthetics, LocalAscorbic AcidBenzocaineMethylene Blue

Autor:innen und Institutionen

  • Department of Pharmacy, Augusta University Medical Center, Augusta, GA, USA.
  • Department of Internal Medicine, Augusta University Medical Center, Augusta, GA, USA.

ORCID-Profile: Kelli R Keats

Zitieren

APA

Keats, K. R., Robinson, R., Patel, M., Wallace, A., & Albrecht, S. (2024). Ascorbic Acid for Methemoglobinemia Treatment: A Case Report and Literature Review. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900231188834

Vancouver

Keats KR, Robinson R, Patel M, Wallace A, Albrecht S. Ascorbic Acid for Methemoglobinemia Treatment: A Case Report and Literature Review. Journal of Pharmacy Practice. 2024. doi:10.1177/08971900231188834

BibTeX
@article{Keats2024,
  author = {Keats, Kelli R and Robinson, Rachel and Patel, Mallika and Wallace, Alexis and Albrecht, Stephanie},
  title = {Ascorbic Acid for Methemoglobinemia Treatment: A Case Report and Literature Review},
  journal = {Journal of Pharmacy Practice},
  year = {2024},
  doi = {10.1177/08971900231188834}
}
Kostenlos starten →